Indication

For adult patients treated with a direct factor Xa (FXa) inhibitor (apixaban or rivaroxaban) when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

Medicine details

Medicine name:
andexanet alfa (Ondexxya)
SMC ID:
SMC2273
Pharmaceutical company
Portola Pharmaceuticals UK Ltd
BNF chapter
Nutrition and blood
Submission type
Full
Publication due date:
07 September 2020